« Omega-3 Fatty Acids Protect Against Parkinson’s, Study Finds
Watson Receives FDA Approval For Generic Combunox »

FDA To Review Abbott’s XIENCE Drug Eluting Heart Stent

Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE V Drug Eluting Heart Stent to FDA Advisory Committee on November 29.

This entry was posted on Tuesday, November 27th, 2007 at 8:10 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.